Presentation is loading. Please wait.

Presentation is loading. Please wait.

Management of hyperuricaemia in patients with gout according to the European League Against Rheumatism recommendations. Management of hyperuricaemia in.

Published byYuliani Lesmana Modified over 5 years ago

Similar presentations

Presentation on theme: "Management of hyperuricaemia in patients with gout according to the European League Against Rheumatism recommendations. Management of hyperuricaemia in."— Presentation transcript:

1 Management of hyperuricaemia in patients with gout according to the European League Against Rheumatism recommendations. Management of hyperuricaemia in patients with gout according to the European League Against Rheumatism recommendations. Letters and numbers in parentheses refer to the items of the recommendations presented in table 1. SUA, serum uric acid; ULT, urate-lowering therapy; XOI, xanthine oxidase inhibitor. ¶At this stage, combined allopurinol and a uricosuric is also recommended. P Richette et al. Ann Rheum Dis doi: /annrheumdis ©2016 by BMJ Publishing Group Ltd and European League Against Rheumatism

Download ppt "Management of hyperuricaemia in patients with gout according to the European League Against Rheumatism recommendations. Management of hyperuricaemia in."

Similar presentations

Gout Update 2014 Bernadette C. Siaton, MD

Gout Update 2014 Bernadette C. Siaton, MD
TXF-00099 Caveat on urate levels Serum uric acid level may be normal at the time of an acute attack. Normal level does not rule out gout. May be better.

TXF Caveat on urate levels Serum uric acid level may be normal at the time of an acute attack. Normal level does not rule out gout. May be better.
Gout: Its not all crystal clear Robert L. Wortmann, M.D. Department of Internal Medicine The University of Oklahoma College of Medicine, Tulsa.

Gout: Its not all crystal clear Robert L. Wortmann, M.D. Department of Internal Medicine The University of Oklahoma College of Medicine, Tulsa.
1 Gout and comorbidities. 2 Background Gout is an inflammatory disease caused by the deposition of monosodium urate (MSU) crystals in joints and other.

1 Gout and comorbidities. 2 Background Gout is an inflammatory disease caused by the deposition of monosodium urate (MSU) crystals in joints and other.
1 Gout management: urate lowering therapy. 2 12 recommendations were produced on the basis of literature evidence and expert opinion Ability to improve.

1 Gout management: urate lowering therapy recommendations were produced on the basis of literature evidence and expert opinion Ability to improve.
HARM APPRAISAL. Is the objective of the article on harm similar to your clinical dilemma?

HARM APPRAISAL. Is the objective of the article on harm similar to your clinical dilemma?
Case discussion Calculi and BPH patient. Medication for this visit Doxazosin 1xhs # 90 Uralyte-U 3 spoons x 3 # 1 bottle MTV 1x2 # 180 Allopurinol 1x2.

Case discussion Calculi and BPH patient. Medication for this visit Doxazosin 1xhs # 90 Uralyte-U 3 spoons x 3 # 1 bottle MTV 1x2 # 180 Allopurinol 1x2.
Angelo L Gaffo Kenneth G Saag Core Evidence 2009:4 25–36

Angelo L Gaffo Kenneth G Saag Core Evidence 2009:4 25–36
Manufacturer: AstraZeneca FDA Approval Date: December 22, 2015

Manufacturer: AstraZeneca FDA Approval Date: December 22, 2015
Joachim Sieper, Désirée van der Heijde, Maxime Dougados, L Steve Brown,Frederic Lavie, Aileen L Pangan Ann Rheum Dis 2012;71:700-706 doi:10.1136/annrheumdis-2011-200358.

Joachim Sieper, Désirée van der Heijde, Maxime Dougados, L Steve Brown,Frederic Lavie, Aileen L Pangan Ann Rheum Dis 2012;71: doi: /annrheumdis
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems

Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review  Robert T. Keenan, MD, MPH 

Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review  Robert T. Keenan, MD, MPH 
OBJECTIVES and METHODOLOGY

OBJECTIVES and METHODOLOGY
Treatment algorithm for hyperuricemia in gout

Treatment algorithm for hyperuricemia in gout
My Treatment Approach to Gout

My Treatment Approach to Gout
Algorithm based on the 2016 European League Against Rheumatism (EULAR) recommendations on rheumatoid arthritis (RA) management. Algorithm based on the.

Algorithm based on the 2016 European League Against Rheumatism (EULAR) recommendations on rheumatoid arthritis (RA) management. Algorithm based on the.
Treat to Target in Gout.

Treat to Target in Gout.
The GR dimer in stromal cells mediates the induction of genes of anti-inflammatory macrophages after DEX treatment in serum transfer-induced arthritis.

The GR dimer in stromal cells mediates the induction of genes of anti-inflammatory macrophages after DEX treatment in serum transfer-induced arthritis.
My Treatment Approach to Gout

My Treatment Approach to Gout
The future of urate-lowering strategies for gout

The future of urate-lowering strategies for gout

Similar presentations

Ads by Google